← Browse by Condition
Medical Condition
hidradenitis suppurativa hs
Total Trials
4
Recruiting Now
4
Trial Phases
Phase 2, Phase 3, Phase 2
NCT07287644 Phase 2, Phase 3
Recruiting
A Study Evaluating BFB759 in Moderate to Severe Hidradenitis Suppurativa
Enrollment
210 pts
Location
United States
Sponsor
Bluefin Biomedicine, Inc.
NCT07109765
Recruiting
Secukinumab Treatment for Moderate to Severe Hidradenitis Suppurativa
Enrollment
50 pts
Location
China
Sponsor
Peking Union Medical College
NCT07021495
Recruiting
SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)
Enrollment
840 pts
Location
Netherlands
Sponsor
Leiden University Medical Cent...
NCT06993610 Phase 2
Recruiting
Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense
Enrollment
225 pts
Location
United States, Canad...
Sponsor
Zura Bio Inc